GLAXO.NS Profit & Loss

Glaxosmithkline Pharmaceuticals Ltd.

Profit & Loss · 4 years on file (FY2022-23 to FY2025-26) · fetched 2026-08-24 01:36

Line item	FY2022-23	FY2023-24	FY2024-25	FY2025-26	Source (XBRL element)
Revenue from Operations	₹32.52 Bn	₹34.54 Bn	₹37.49 Bn	₹38.22 Bn	RevenueFromOperations
Gross Revenue (incl. inter-segment)	N/A	N/A	N/A	N/A	SegmentRevenueFromOperations
Other Income	₹1.01 Bn	₹1.23 Bn	₹1.46 Bn	₹1.45 Bn	OtherIncome
Total Income	₹33.52 Bn	₹35.76 Bn	₹38.95 Bn	₹39.67 Bn	Income
Cost of Materials Consumed	₹4.27 Bn	₹5.45 Bn	₹5.00 Bn	₹4.36 Bn	CostOfMaterialsConsumed
Purchases of Stock-in-Trade	₹7.88 Bn	₹8.53 Bn	₹8.45 Bn	₹9.10 Bn	PurchasesOfStockInTrade
Changes in Inventories	₹0.69 Bn	₹-0.64 Bn	₹0.46 Bn	₹0.04 Bn	ChangesInInventoriesOfFinishedGoodsWorkInProgressAndStockInTrade
Employee Benefit Expense	₹5.95 Bn	₹6.24 Bn	₹5.80 Bn	₹6.07 Bn	EmployeeBenefitExpense
Finance Costs	₹0.02 Bn	₹0.02 Bn	₹0.01 Bn	₹0.03 Bn	FinanceCosts
Depreciation and Amortisation	₹0.66 Bn	₹0.70 Bn	₹0.67 Bn	₹0.66 Bn	DepreciationDepletionAndAmortisationExpense
Other Expenses	₹5.68 Bn	₹5.86 Bn	₹6.01 Bn	₹5.54 Bn	OtherExpenses
Total Expenses	₹25.15 Bn	₹26.16 Bn	₹26.40 Bn	₹25.82 Bn	Expenses
Profit Before Exceptional Items and Tax	₹8.37 Bn	₹9.60 Bn	₹12.55 Bn	₹13.85 Bn	ProfitBeforeExceptionalItemsAndTax
Exceptional Items	₹-0.01 Bn	₹-1.44 Bn	₹0.05 Bn	₹0.21 Bn	ExceptionalItemsBeforeTax
Profit Before Tax	₹8.36 Bn	₹8.16 Bn	₹12.60 Bn	₹14.06 Bn	ProfitBeforeTax
Tax Expense	₹2.29 Bn	₹2.26 Bn	₹3.32 Bn	₹3.70 Bn	TaxExpense
Net Profit (incl. minority interest)	₹6.11 Bn	₹5.90 Bn	₹9.28 Bn	₹10.36 Bn	ProfitLossForPeriod
Net Profit (to shareholders)	₹6.11 Bn	₹5.90 Bn	₹0.00 Bn	N/A	ProfitOrLossAttributableToOwnersOfParent
Basic EPS	₹36.05	₹34.83	₹54.52	₹54.52	BasicEarningsLossPerShareFromContinuingAndDiscontinuedOperations
Diluted EPS	₹36.05	₹34.83	₹54.76	₹54.76	DilutedEarningsLossPerShareFromContinuingAndDiscontinuedOperations

Every figure above is the exact value of the named XBRL element from GLAXO.NS's cached filing for that year — nothing here is estimated or backfilled. A company shows one column per year StockProof actually has data for — never padded with blank years. Rows shown as N/A are genuinely not disclosed under that year's filing format (see peer comparison for how other Healthcare companies compare).